tiprankstipranks
Advertisement
Advertisement
Fortress Biotech Gains FDA Approval for Menkes Treatment
PremiumCompany AnnouncementsFortress Biotech Gains FDA Approval for Menkes Treatment
4M ago
Fortress Biotech, Cyprium announce FDA approval of ZYCUBO
Premium
The Fly
Fortress Biotech, Cyprium announce FDA approval of ZYCUBO
4M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
Fortress Biotech, Cyprium announce FDA acceptance of CUTX-101 NDA resubmission
PremiumThe FlyFortress Biotech, Cyprium announce FDA acceptance of CUTX-101 NDA resubmission
5M ago
Fortress Biotech price target raised to $4.50 from $4 at Alliance Global
Premium
The Fly
Fortress Biotech price target raised to $4.50 from $4 at Alliance Global
6M ago
Fortress Biotech’s Subsidiary Resubmits NDA for CUTX-101
Premium
Company Announcements
Fortress Biotech’s Subsidiary Resubmits NDA for CUTX-101
6M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
7M ago
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
7M ago
Fortress Biotech: Buy Rating Affirmed Amid Strategic Developments and Financial Upside
Premium
Ratings
Fortress Biotech: Buy Rating Affirmed Amid Strategic Developments and Financial Upside
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100